Viawealth LLC Sells 582 Shares of UnitedHealth Group Incorporated $UNH

Viawealth LLC lowered its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 7.3% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 7,417 shares of the healthcare conglomerate’s stock after selling 582 shares during the period. UnitedHealth Group comprises about 1.4% of Viawealth LLC’s holdings, making the stock its 15th largest holding. Viawealth LLC’s holdings in UnitedHealth Group were worth $2,314,000 at the end of the most recent reporting period.

Several other hedge funds have also added to or reduced their stakes in the business. Nuveen LLC purchased a new position in shares of UnitedHealth Group in the first quarter worth $3,846,764,000. Vanguard Group Inc. increased its stake in shares of UnitedHealth Group by 6.6% in the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate’s stock worth $47,519,620,000 after acquiring an additional 5,583,343 shares in the last quarter. Wellington Management Group LLP grew its stake in shares of UnitedHealth Group by 10.6% in the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate’s stock worth $13,537,859,000 after buying an additional 2,486,839 shares during the last quarter. Davis Selected Advisers raised its position in shares of UnitedHealth Group by 2,234.9% in the 2nd quarter. Davis Selected Advisers now owns 1,132,885 shares of the healthcare conglomerate’s stock worth $353,426,000 after purchasing an additional 1,084,366 shares during the last quarter. Finally, National Bank of Canada FI boosted its stake in UnitedHealth Group by 137.8% during the 1st quarter. National Bank of Canada FI now owns 1,641,177 shares of the healthcare conglomerate’s stock valued at $859,518,000 after purchasing an additional 950,928 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of analysts have recently commented on UNH shares. Truist Financial lifted their price target on shares of UnitedHealth Group from $310.00 to $365.00 and gave the stock a “buy” rating in a research note on Tuesday, September 9th. The Goldman Sachs Group started coverage on UnitedHealth Group in a research report on Tuesday, October 14th. They issued a “buy” rating and a $406.00 price target for the company. Jefferies Financial Group upped their price target on UnitedHealth Group from $317.00 to $409.00 and gave the stock a “buy” rating in a research note on Friday, October 17th. TD Cowen lifted their price objective on UnitedHealth Group from $335.00 to $338.00 and gave the stock a “hold” rating in a research note on Thursday, October 30th. Finally, Leerink Partners set a $410.00 price objective on shares of UnitedHealth Group and gave the stock an “outperform” rating in a research note on Wednesday, October 29th. Eighteen analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $397.12.

UnitedHealth Group Trading Up 2.3%

NYSE UNH opened at $326.23 on Wednesday. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $622.83. The company’s 50-day moving average price is $343.84 and its 200-day moving average price is $315.01. The stock has a market cap of $295.51 billion, a PE ratio of 17.03, a PEG ratio of 2.28 and a beta of 0.47. The company has a current ratio of 0.82, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, topping analysts’ consensus estimates of $2.87 by $0.05. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The business had revenue of $113.16 billion for the quarter, compared to analyst estimates of $113.19 billion. During the same period last year, the company posted $7.15 earnings per share. The company’s quarterly revenue was up 12.2% compared to the same quarter last year. Equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 16th. Stockholders of record on Monday, December 8th will be given a $2.21 dividend. The ex-dividend date of this dividend is Monday, December 8th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.7%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 46.14%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.